Novel regulation of the transcription factor ZHX2 by N-terminal methylation. Issue 1 (27th May 2022)

• Record Type: Journal Article
• Authors: Conner, Meghan M.; Parker, Haley V.; Falcone, Daniela R.; Chung, Gehoon; Schaner Tooley, Christine E.
• Is Part Of: Transcription. Volume 13:Issue 1/3(2022)
• Page Start: 1
• Page End: 15
• Publication Date: 2022-05-27
• Subjects: ZHX2 -- NRMT1 -- GPC3 -- H19 lncRNA -- methylation -- liver; Genetic transcription -- Periodicals; 572.8
• DOI: 10.1080/21541264.2022.2079184
• Languages: English
• ISSNs: 2154-1264

Abstract

ABSTRACT: N-terminal methylation (Nα-methylation) by the methyltransferase NRMT1 is an important post-translational modification that regulates protein–DNA interactions. Accordingly, its loss impairs functions that are reliant on such interactions, including DNA repair and transcriptional regulation. The global loss of Nα-methylation results in severe developmental and premature aging phenotypes, but given over 300 predicted substrates, it is hard to discern which physiological substrates contribute to each phenotype. One of the most striking phenotypes in NRMT1 knockout ( Nrmt1 −/− ) mice is early liver degeneration. To identify the disrupted signaling pathways leading to this phenotype and the NRMT1 substrates involved, we performed RNA-sequencing analysis of control and Nrmt1 −/− adult mouse livers. We found both a significant upregulation of transcripts in the cytochrome P450 (CYP) family and downregulation of transcripts in the major urinary protein (MUP) family. Interestingly, transcription of both families is inversely regulated by the transcription factor zinc fingers and homeoboxes 2 (ZHX2). ZHX2 contains a non-canonical NRMT1 consensus sequence, indicating that its function could be directly regulated by Nα-methylation. We confirmed misregulation of CYP and MUP mRNA and protein levels in Nrmt1 −/− livers and verified NRMT1 can methylate ZHX2 in vitro . In addition, we used a mutant of ZHX2 that cannot be methylated to directly demonstrate Nα-methylation promotes ZHX2 transcription factor activity and target promoter occupancy. Finally, we show Nrmt1 −/− mice also exhibit early postnatal de-repression of ZHX2 targets involved in fetal liver development. Taken together, these data implicate ZHX2 misregulation as a driving force behind the liver phenotype seen in Nrmt1 −/− mice.